Re-imagining Oral Semaglutide in Routine Clinical Practice: Indian Expert Panel Recommendations

Background: The rising prevalence of type 2 diabetes mellitus (T2DM) in India, driven by obesity and lifestyle factors, necessitates innovative treatments like oral Semaglutide, a GLP-1 receptor agonist (GLP-1RA). Its oral formulation enhances patient adherence by overcoming barriers associated with...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Aravinda Jagadeesha, Banshi Saboo, Subhash K Wangnoo, Kalyan Kumar Gangopadhyay, Jothydev Kesavadev, Ganapathi Bantwal, Pramila Kalra, Hemant P Thacker, Sonali Patange
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Wolters Kluwer Medknow Publications 2025-07-01
Edice:	International Journal of Diabetes and Technology
Témata:	cardiovascular diseases semaglutide type 2 diabetes mellitus
On-line přístup:	https://journals.lww.com/10.4103/ijdt.ijdt_18_25
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!